Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Tofacitinib treatment is used for teenagers with alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Nilotinib can cause skin issues like red bumps and hair loss.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Erlotinib can cause hair loss as a side effect.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Baricitinib successfully treated severe hair loss.